22nd Century Group Depreciation & Amortization 2011-2026 | XXII

Annual Depreciation & Amortization 22nd Century Group

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
852 K	673 K	1.25 M	688 K	1.19 M	1.2 M	849 K	744 K	676 K	463 K	144 K	198 K	180 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.25 M	144 K	700 K

Quarterly Depreciation & Amortization 22nd Century Group

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
123 K	122 K	103 K	-	143 K	144 K	104 K	-	168 K	165 K	162 K	-	178 K	163 K	161 K	-	168 K	153 K	138 K	-	160 K	157 K	268 K	-	158 K	147 K	291 K	-	857 K	545 K	268 K	-	622 K	411 K	205 K	-	550 K	364 K	181 K	-	498 K	325 K	161 K	-	326 K	196 K	71.3 K	-	173 K	57 K	52.6 K	-	50.5 K	50 K	46 K	-	44.6 K	44.2 K	43.6 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
857 K	43.6 K	211 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Adagene ADAG	723 K	$ 2.62	28.82 %	$ 147 M	China
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 25.92	-0.86 %	$ 1.26 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Ultragenyx Pharmaceutical RARE	35.5 M	$ 24.45	4.49 %	$ 2.21 B	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
BioXcel Therapeutics BTAI	309 K	$ 1.84	1.66 %	$ 4.66 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.66	-1.85 %	$ 16.7 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	22.2 M	$ 67.49	-3.02 %	$ 9.03 B	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 4.51	8.41 %	$ 9.81 B	Israel
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Coherus BioSciences CHRS	3.2 M	$ 2.04	28.3 %	$ 192 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Biogen BIIB	673 M	$ 171.89	-1.1 %	$ 25 B	USA
Bio-Path Holdings BPTH	82 K	-	-	$ 100 K	USA
BioVie BIVI	229 K	$ 1.2	-3.7 %	$ 1.77 M	USA